http://e.ccialerts.com/a/hBKXG$9AHJQfmAUDSLFASbv4uD0/clck63
Novo Nordisk, Spokesman Pay Extra Care to Regulatory Issues
**
NEW YORK (AdAge.com) — Scrutiny of direct-to-consumer advertising from the Food and Drug Administration may be heightening, but that has not deterred one pharmaceutical company from trying something new for the industry: a branded Twitter page.
FULL ARTICLE http://e.ccialerts.com/a/hBKXG$9AHJQfmAUDSLFASbv4uD0/clck63
